Fundz

Tmunity Therapeutics, Inc. reported raising $75 Million in an initial SEC Form D filing, from an offering of $75 Million

PRIVATEOct 30, 2019

Amount Raised

$75 Million

$75 Million sold, per SEC Form D (first sale Oct 30, 2019)

Round Type

Venture

PhiladelphiaManufacturingBiotechnologyHealthcareTherapeutics

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Tmunity Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Sarepta Therapeutics raised $30M on November 25, 2019.
  • Palvella Therapeutics, Inc. raised $32M on November 20, 2019.
  • Revolution Medicines raised $100M on November 15, 2019.
  • ISOThrive raised $4M on November 14, 2019.
  • RedHill Biopharma Ltd raised $48M on November 6, 2019.
  • MindImmune Therapeutics raised $750K on November 1, 2019.

Who to call at Tmunity Therapeutics, Inc., and when

A new round usually means Tmunity Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tmunity Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tmunity Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tmunity Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tmunity Therapeutics, Inc.

Location

3020 MARKET STREET

Philadelphia, Pennsylvania, United States

About

​Tmunity is a private, clinical-stage biotechnology company focused on transforming the future of CAR-T therapies by developing the next generation of engineered T-cell therapies, innovative manufacturing process and technologies. Programs are multi-armored with broader therapeutic-index to benefit patients with hematologic malignancies and advanced solid tumors, including those who have relapsed after receiving CAR-T treatment. Integrating the research and development collaboration with the University of Pennsylvania (Penn) with the expertise and demonstrated track record of its founders with Tmunity teams’ scientific experience enables efficient implementation of cutting-edge insights in T-cell engineering, manufacturing, clinical development and patient management. Headquartered in Philadelphia -- for more information, visit www.tmunity.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tmunity Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Tmunity Therapeutics, Inc.'s next move

See what Strategic adds

Tmunity Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.